NNNNNasdaq

Anbio Biotechnology

In Vitro & In Vivo Diagnostic Substances · E9 · CIK 1982708

Anbio Biotechnology offers innovative products and services, facing risks in development, market acceptance, and regulatory compliance

$684M

Market cap

$13.71

Last close

+1.2%

-12.7%

47K

Volume

Price · last 40 sessions-54.3%

May 4L $13.55 · H $34.44Jun 30

Total filings

May 19, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance